215 related articles for article (PubMed ID: 32248732)
21. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
[TBL] [Abstract][Full Text] [Related]
22. Deletions in CCM2 are a common cause of cerebral cavernous malformations.
Liquori CL; Berg MJ; Squitieri F; Leedom TP; Ptacek L; Johnson EW; Marchuk DA
Am J Hum Genet; 2007 Jan; 80(1):69-75. PubMed ID: 17160895
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
[TBL] [Abstract][Full Text] [Related]
24. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
25. Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
Li W; Tran V; Shaked I; Xue B; Moore T; Lightle R; Kleinfeld D; Awad IA; Ginsberg MH
Elife; 2021 May; 10():. PubMed ID: 34013885
[TBL] [Abstract][Full Text] [Related]
26. KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.
Guzeloglu-Kayisli O; Amankulor NM; Voorhees J; Luleci G; Lifton RP; Gunel M
Neurosurgery; 2004 Apr; 54(4):943-9; discussion 949. PubMed ID: 15046662
[TBL] [Abstract][Full Text] [Related]
27. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
[TBL] [Abstract][Full Text] [Related]
28. Amplification of protease-activated receptors signaling in sporadic cerebral cavernous malformation endothelial cells.
Scimone C; Alibrandi S; Donato L; De Gaetano GV; Fusco C; Nardella G; Castori M; Rinaldi C; Alafaci C; Germanò A; D'Angelo R; Sidoti A
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119474. PubMed ID: 37030452
[TBL] [Abstract][Full Text] [Related]
29. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.
Choi JP; Zheng X
Methods Mol Biol; 2020; 2152():253-258. PubMed ID: 32524557
[TBL] [Abstract][Full Text] [Related]
30. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans.
Gunel M; Awad IA; Finberg K; Anson JA; Steinberg GK; Batjer HH; Kopitnik TA; Morrison L; Giannotta SL; Nelson-Williams C; Lifton RP
N Engl J Med; 1996 Apr; 334(15):946-51. PubMed ID: 8596595
[TBL] [Abstract][Full Text] [Related]
31. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations.
Verlaan DJ; Laurent SB; Sure U; Bertalanffy H; Andermann E; Andermann F; Rouleau GA; Siegel AM
Neurology; 2004 Apr; 62(7):1213-5. PubMed ID: 15079030
[TBL] [Abstract][Full Text] [Related]
32. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
33. Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).
Ortiz L; Costa AF; Bellido ML; Solano F; García-Moreno JM; Gamero MA; Izquierdo G; Chadli A; Falcao F; Ferro J; Salas J; Alvarez-Cermeño JC; Montori M; Ramos-Arroyo MA; Palomino A; Pintado E; Lucas M
J Neurol; 2007 Mar; 254(3):322-6. PubMed ID: 17345049
[TBL] [Abstract][Full Text] [Related]
34. CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study.
Scimone C; Bramanti P; Ruggeri A; Donato L; Alafaci C; Crisafulli C; Mucciardi M; Rinaldi C; Sidoti A; D'Angelo R
BMC Med Genet; 2016 Oct; 17(1):74. PubMed ID: 27737651
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
36. Cerebral cavernous malformation: new molecular and clinical insights.
Revencu N; Vikkula M
J Med Genet; 2006 Sep; 43(9):716-21. PubMed ID: 16571644
[TBL] [Abstract][Full Text] [Related]
37. Increased number of white matter lesions in patients with familial cerebral cavernous malformations.
Golden MJ; Morrison LA; Kim H; Hart BL
AJNR Am J Neuroradiol; 2015 May; 36(5):899-903. PubMed ID: 25556204
[TBL] [Abstract][Full Text] [Related]
38. Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations.
Cavé-Riant F; Denier C; Labauge P; Cécillon M; Maciazek J; Joutel A; Laberge-Le Couteulx S; Tournier-Lasserve E
Eur J Hum Genet; 2002 Nov; 10(11):733-40. PubMed ID: 12404106
[TBL] [Abstract][Full Text] [Related]
39. First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing.
Spiegler S; Rath M; Hoffjan S; Dammann P; Sure U; Pagenstecher A; Strom T; Felbor U
Neurogenetics; 2018 Jan; 19(1):55-59. PubMed ID: 29197946
[TBL] [Abstract][Full Text] [Related]
40. Genetics of cerebral cavernous malformations: current status and future prospects.
Choquet H; Pawlikowska L; Lawton MT; Kim H
J Neurosurg Sci; 2015 Sep; 59(3):211-20. PubMed ID: 25900426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
